Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis

NCT02047734 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1320

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG: Ozanimod
DRUG: Ozanimod placebo
DRUG: Interferon beta-1a
DRUG: Interferon beta-1a placebo

Sponsor

Celgene